Navigation Links
COPAN Files New Patents Following the Development of High Nucleic Acid Yield Flocked Swabs
Date:12/16/2010

MURRIETA, Calif., Dec. 16, 2010 /PRNewswire/ -- COPAN has enjoyed widespread use of its flocked swabs line, branded as FLOQSwabs, in microbiology for the collection and transportation of bacterial and viral samples.

FLOQSwabs by COPAN have been shown through numerous independent studies to collect more sample and elute the entire sample thus improving the detection and diagnosis of infectious disease agents. In spite of this success, the company has remained committed to continual innovation to optimize the sample collection, preservation and maximize the release of the target analyte into numerous assay platforms. New research at COPAN has led to an important technological breakthrough in the yield of target nucleic acid from its FLOQSwabs.  In the case of Low Copy Numbers (LCN) when minute quantities of nucleic acid might be present in a sample, maximum yield of nucleic acid can make the difference between a positive or negative result.

Even though FLOQSwabs release almost the entire sample, nucleic acid has a tendency to be sticky and some residue can still attach to swab fibers. This risk is eliminated with COPAN's latest discovery in fiber treatment for flocked swabs. COPAN's high nucleic acid yield FLOQSwabs now deliver as much as 1 log more nucleic acid, equivalent to 3 PCR cycles less for detection. This demonstrable improvement is another milestone in the evolution of flocked swab technology and ensures the maximum sensitivity of assay. The recent discoveries are now the subject of a series of new patent applications by COPAN in the USA and in other countries around the world.

Worldwide, COPAN holds numerous patents for its original line of flocked swabs, FLOQSwabs.

About Copan Group

With a reputation for innovation in preanalytics, Copan is the leading manufacturer of collection and transport systems in the world. COPAN offers a complete range of microbial sampling products used for traditional culture analysis and molecular diagnostic assays. For more information, visit www.copanusa.com


'/>"/>
SOURCE Copan Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. COPAN Secures Japanese Patent for its Flocked Swab Innovation
2. Copan Redefines Automated Specimen Processing with Groundbreaking New Features
3. Cell Therapeutics Files Appeal on FDA Decision on New Drug Application (NDA) for Pixantrone to Treat Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma
4. AcelRx Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
5. ERT Files Shelf Registration Statement
6. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
7. Chesley Files Class Action Against DePuy Orthopaedics
8. Gen-Probe Files US Regulatory Application for Molecular Test to Detect Common Sexually Transmitted Disease Trichomonas Vaginalis
9. Peptimmune Files Citizen Petition Regarding Generic Copaxone and Demonstrates Significant Enabling Technology for Biological Characterization of Copaxone
10. Volcano Corporation Files Counterclaim Asserting St. Jude Infringes Three Volcano Patents; Answers St. Judes Patent Infringement Claims
11. China-Biotics Files New Patent Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... 7, 2016 The global  ... value of USD 3.9 billion by 2024, based ... Inc. The growth of the market is attributed ... technological advancements by the market players. Demand for ... increasing donation, rising awareness about transfusion-transmitted diseases, and ...
(Date:12/6/2016)... -- Licenders is bringing their 100% all-natural lice removal service to ... 203 13 th Street was specifically chosen to make treatment ... "Our goal is to ease parents, stress and bring their lives ... right back to class without skipping a beat. The best part ... the whole family," Licenders President Adie Horowitz states. ...
(Date:12/6/2016)... 6, 2016  Alopexx Oncology, LLC announced data from ... fusion protein (immunocytokine) composed of interleukin-2 and a CD20-targeting ... on B cells as Rituxan and maintains the activities ... also involved in tumor targeting, engagement of the immune ... results of the study (abstract #95954) were presented at ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... 2016 , ... The Business Architecture Guild is ... on March 21-22, 2017. This premier event features business practitioners and experts from ... of industries such as financial services, insurance, healthcare, manufacturing, transportation, retail, and utilities. ...
(Date:12/7/2016)... San Mateo, CA (PRWEB) , ... December 07, 2016 , ... ... entire San Francisco Peninsula region, is proud to announce new city-specific pages as part ... care services for the elderly, they often look, first, for local agencies serving their ...
(Date:12/6/2016)... ... 06, 2016 , ... People with Parkinson’s disease and cognitive ... type of MRI, according to a study appearing online in the journal Radiology. ... characterized by tremors or trembling and stiffness in the limbs, impaired balance and ...
(Date:12/6/2016)... ... December 06, 2016 , ... Men with gum disease ... of serious health problems, such as cardiovascular illness, according to research cited in ... Hills Periodontics & Dental Implant Center notes that the correlation between periodontal disease ...
(Date:12/6/2016)... ... December 06, 2016 , ... According to a November 1 article ... too many mints or not drinking enough water, which can cause bad breath (known ... notes that good oral hygiene not only helps reduce the possibility of bad breath, ...
Breaking Medicine News(10 mins):